Ischemia/reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1

Molecular Pharmaceutics

Volumn 10, Issue 7, 2013, Pages 2578-2587

  Li, Qing ^a,b   Yang, Hyekyung ^a   Peng, Xiujuan ^a   Guo, Dong ^b   Dong, Zhongqi ^a   Polli, James E ^a   Shu, Yan ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

drug transporter; hydrodynamic tail vein injection; Iischemia reperfusion inducible protein; multidrug and toxin extrusion; obesity; organic cation transporter

Indexed keywords

ISCHEMIA REPERFUSION INDUCIBLE PROTEIN; MATE1 PROTEIN; METFORMIN; ORGANIC CATION TRANSPORTER 1; PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE OVEREXPRESSION; GENE SILENCING; HYDRODYNAMICS; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; CARRIER PROTEINS; CELL LINE; GTP-BINDING PROTEINS; HUMANS; LIVER; MALE; METFORMIN; MICE; ORGANIC CATION TRANSPORT PROTEINS; ORGANIC CATION TRANSPORTER 1; RNA-BINDING PROTEINS;

EID: 84879737430     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400013t     Document Type: Article

References (57)

1. Giacomini, K. M.; Huang, S. M.; Tweedie, D. J.; Benet, L. Z.; Brouwer, K. L.; Chu, X.; Dahlin, A.; Evers, R.; Fischer, V.; Hillgren, K. M.; Hoffmaster, K. A.; Ishikawa, T.; Keppler, D.; Kim, R. B.; Lee, C. A.; Niemi, M.; Polli, J. W.; Sugiyama, Y.; Swaan, P. W.; Ware, J. A.; Wright, S. H.; Yee, S. W.; Zamek-Gliszczynski, M. J.; Zhang, L. Membrane transporters in drug development Na. Rev. Drug Discovery 2010, 9 (3) 215-36
2. Hagenbuch, B.; Gui, C. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family Xenobiotica 2008, 38 (7-8) 778-801
3. Koepsell, H.; Lips, K.; Volk, C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications Pharm. Res. 2007, 24 (7) 1227-51
4. VanWert, A. L.; Gionfriddo, M. R.; Sweet, D. H. Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology Biopharm. Drug Dispos. 2010, 31 (1) 1-71
5. Lagas, J. S.; Vlaming, M. L.; Schinkel, A. H. Pharmacokinetic assessment of multiple ATP-binding cassette transporters: the power of combination knockout mice Mol. Interventions 2009, 9 (3) 136-45
6. Shu, Y.; Sheardown, S. A.; Brown, C.; Owen, R. P.; Zhang, S.; Castro, R. A.; Ianculescu, A. G.; Yue, L.; Lo, J. C.; Burchard, E. G.; Brett, C. M.; Giacomini, K. M. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action J. Clin. Invest. 2007, 117 (5) 1422-31
7. Shu, Y.; Brown, C.; Castro, R. A.; Shi, R. J.; Lin, E. T.; Owen, R. P.; Sheardown, S. A.; Yue, L.; Burchard, E. G.; Brett, C. M.; Giacomini, K. M. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics Clin. Pharmacol. Ther. 2008, 83 (2) 273-80
8. Jiang, W.; Prokopenko, O.; Wong, L.; Inouye, M.; Mirochnitchenko, O. IRIP, a new ischemia/reperfusion-inducible protein that participates in the regulation of transporter activity Mol. Cell. Biol. 2005, 25 (15) 6496-508
9. Prokopenko, O.; Mirochnitchenko, O. Ischemia-reperfusion-inducible protein modulates cell sensitivity to anticancer drugs by regulating activity of efflux transporter Am. J. Physiol. 2009, 296 (5) C1086-97
10. Galperin, M. Y.; Koonin, E. V. 'Conserved hypothetical' proteins: prioritization of targets for experimental study Nucleic Acids Res. 2004, 32 (18) 5452-63
11. Teplova, M.; Tereshko, V.; Sanishvili, R.; Joachimiak, A.; Bushueva, T.; Anderson, W. F.; Egli, M. The structure of the yrdC gene product from Escherichia coli reveals a new fold and suggests a role in RNA binding Protein Sci. 2000, 9 (12) 2557-66
12. El Yacoubi, B.; Lyons, B.; Cruz, Y.; Reddy, R.; Nordin, B.; Agnelli, F.; Williamson, J. R.; Schimmel, P.; Swairjo, M. A.; de Crecy-Lagard, V. The universal YrdC/Sua5 family is required for the formation of threonylcarbamoyladenosine in tRNA Nucleic Acids Res. 2009, 37 (9) 2894-909
13. Kaczanowska, M.; Ryden-Aulin, M. The YrdC protein - a putative ribosome maturation factor Biochim. Biophys. Acta 2005, 1727 (2) 87-96
14. Agari, Y.; Sato, S.; Wakamatsu, T.; Bessho, Y.; Ebihara, A.; Yokoyama, S.; Kuramitsu, S.; Shinkai, A. X-ray crystal structure of a hypothetical Sua5 protein from Sulfolobus tokodaii strain 7 Proteins 2008, 70 (3) 1108-11
15. Lin, C. A.; Ellis, S. R.; True, H. L. The Sua5 protein is essential for normal translational regulation in yeast Mol. Cell. Biol. 2010, 30 (1) 354-63
16. Meng, F. L.; Chen, X. F.; Hu, Y.; Tang, H. B.; Dang, W.; Zhou, J. Q. Sua5p is required for telomere recombination in Saccharomyces cerevisiae Cell Res. 2010, 20 (4) 495-8
17. Na, J. G.; Pinto, I.; Hampsey, M. Isolation and characterization of SUA5, a novel gene required for normal growth in Saccharomyces cerevisiae Genetics 1992, 131 (4) 791-801
18. Nies, A. T.; Koepsell, H.; Winter, S.; Burk, O.; Klein, K.; Kerb, R.; Zanger, U. M.; Keppler, D.; Schwab, M.; Schaeffeler, E. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver Hepatology 2009, 50 (4) 1227-40
19. Zolk, O.; Solbach, T. F.; Konig, J.; Fromm, M. F. Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2) Naunyn-Schmiedeberg's Arch. Pharmacol. 2009, 379 (4) 337-48
20. Otsuka, M.; Matsumoto, T.; Morimoto, R.; Arioka, S.; Omote, H.; Moriyama, Y. A human transporter protein that mediates the final excretion step for toxic organic cations Proc. Natl. Acad. Sci. U.S.A. 2005, 102 (50) 17923-8
21. Masuda, S.; Terada, T.; Yonezawa, A.; Tanihara, Y.; Kishimoto, K.; Katsura, T.; Ogawa, O.; Inui, K. Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2 J. Am. Soc. Nephrol. 2006, 17 (8) 2127-35
22. Omote, H.; Hiasa, M.; Matsumoto, T.; Otsuka, M.; Moriyama, Y. The MATE proteins as fundamental transporters of metabolic and xenobiotic organic cations Trends Pharmacol. Sci. 2006, 27 (11) 587-93
23. Tanihara, Y.; Masuda, S.; Sato, T.; Katsura, T.; Ogawa, O.; Inui, K. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters Biochem. Pharmacol. 2007, 74 (2) 359-71
24. Damme, K.; Nies, A. T.; Schaeffeler, E.; Schwab, M. Mammalian MATE (SLC47A) transport proteins: impact on efflux of endogenous substrates and xenobiotics Drug Metab. Rev. 2011, 43 (4) 499-523
25. Matsuzaki, T.; Morisaki, T.; Sugimoto, W.; Yokoo, K.; Sato, D.; Nonoguchi, H.; Tomita, K.; Terada, T.; Inui, K.; Hamada, A.; Saito, H. Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury Drug Metab. Dispos. 2008, 36 (4) 649-54
26. Cheng, Q.; Aleksunes, L. M.; Manautou, J. E.; Cherrington, N. J.; Scheffer, G. L.; Yamasaki, H.; Slitt, A. L. Drug-metabolizing enzyme and transporter expression in a mouse model of diabetes and obesity Mol. Pharmaceutics 2008, 5 (1) 77-91
27. More, V. R.; Slitt, A. L. Alteration of hepatic but not renal transporter expression in diet-induced obese mice Drug Metab. Dispos. 2011, 39 (6) 992-9
28. Sauvant, C.; Schneider, R.; Holzinger, H.; Renker, S.; Wanner, C.; Gekle, M. Implementation of an in vitro model system for investigation of reperfusion damage after renal ischemia Cell. Physiol. Biochem. 2009, 24 (5-6) 567-76
29. Shu, Y.; Leabman, M. K.; Feng, B.; Mangravite, L. M.; Huang, C. C.; Stryke, D.; Kawamoto, M.; Johns, S. J.; DeYoung, J.; Carlson, E.; Ferrin, T. E.; Herskowitz, I.; Giacomini, K. M. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1 Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (10) 5902-7
30. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 2001, 25 (4) 402-8
31. Denk, G. U.; Soroka, C. J.; Mennone, A.; Koepsell, H.; Beuers, U.; Boyer, J. L. Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis Hepatology 2004, 39 (5) 1382-9
32. Cui, Y.; Konig, J.; Buchholz, J. K.; Spring, H.; Leier, I.; Keppler, D. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells Mol. Pharmacol. 1999, 55 (5) 929-37
33. Sawyer, G. J.; Rela, M.; Davenport, M.; Whitehorne, M.; Zhang, X.; Fabre, J. W. Hydrodynamic gene delivery to the liver: theoretical and practical issues for clinical application Curr. Gene Ther. 2009, 9 (2) 128-35
34. Wooddell, C. I.; Reppen, T.; Wolff, J. A.; Herweijer, H. Sustained liver-specific transgene expression from the albumin promoter in mice following hydrodynamic plasmid DNA delivery J. Gene Med. 2008, 10 (5) 551-63
35. Wang, D. S.; Jonker, J. W.; Kato, Y.; Kusuhara, H.; Schinkel, A. H.; Sugiyama, Y. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin J. Pharmacol. Exp. Ther. 2002, 302 (2) 510-5
36. Li, Q.; Peng, X.; Yang, H.; Wang, H.; Shu, Y. Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice Mol. Pharmaceutics 2011, 8 (6) 2476-83
37. Tsuda, M.; Terada, T.; Mizuno, T.; Katsura, T.; Shimakura, J.; Inui, K. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin Mol. Pharmacol. 2009, 75 (6) 1280-6
38. Chen, L.; Pawlikowski, B.; Schlessinger, A.; More, S. S.; Stryke, D.; Johns, S. J.; Portman, M. A.; Chen, E.; Ferrin, T. E.; Sali, A.; Giacomini, K. M. Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin Pharmacogenet. Genomics 2010, 20 (11) 687-99
39. Reinhardt, J.; Veyhl, M.; Wagner, K.; Gambaryan, S.; Dekel, C.; Akhoundova, A.; Korn, T.; Koepsell, H. Cloning and characterization of the transport modifier RS1 from rabbit which was previously assumed to be specific for Na+-D-glucose cotransport Biochim. Biophys. Acta 1999, 1417 (1) 131-43
40. Veyhl, M.; Keller, T.; Gorboulev, V.; Vernaleken, A.; Koepsell, H. RS1 (RSC1A1) regulates the exocytotic pathway of Na+-D-glucose cotransporter SGLT1 Am. J. Physiol. 2006, 291 (6) F1213-23
41. Veyhl, M.; Wagner, C. A.; Gorboulev, V.; Schmitt, B. M.; Lang, F.; Koepsell, H. Downregulation of the Na(+)- D-glucose cotransporter SGLT1 by protein RS1 (RSC1A1) is dependent on dynamin and protein kinase C J. Membr. Biol. 2003, 196 (1) 71-81
42. Errasti-Murugarren, E.; Fernandez-Calotti, P.; Veyhl-Wichmann, M.; Diepold, M.; Pinilla-Macua, I.; Perez-Torras, S.; Kipp, H.; Koepsell, H.; Pastor-Anglada, M. Role of the transporter regulator protein (RS1) in the modulation of concentrative nucleoside transporters (CNTs) in epithelia Mol. Pharmacol. 2012, 82 (1) 59-67
43. Kroiss, M.; Leyerer, M.; Gorboulev, V.; Kuhlkamp, T.; Kipp, H.; Koepsell, H. Transporter regulator RS1 (RSC1A1) coats the trans-Golgi network and migrates into the nucleus Am. J. Physiol. 2006, 291 (6) F1201-12
44. Filatova, A.; Leyerer, M.; Gorboulev, V.; Chintalapati, C.; Reinders, Y.; Muller, T. D.; Srinivasan, A.; Hubner, S.; Koepsell, H. Novel shuttling domain in a regulator (RSC1A1) of transporter SGLT1 steers cell cycle-dependent nuclear location Traffic 2009, 10 (11) 1599-618
45. Korn, T.; Kuhlkamp, T.; Track, C.; Schatz, I.; Baumgarten, K.; Gorboulev, V.; Koepsell, H. The plasma membrane-associated protein RS1 decreases transcription of the transporter SGLT1 in confluent LLC-PK1 cells J. Biol. Chem. 2001, 276 (48) 45330-40
46. Scheen, A. J. Clinical pharmacokinetics of metformin Clin. Pharmacokinet. 1996, 30 (5) 359-71
47. Zhou, M.; Xia, L.; Wang, J. Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine Drug Metab. Dispos. 2007, 35 (10) 1956-62
48. Christensen, M. M.; Brasch-Andersen, C.; Green, H.; Nielsen, F.; Damkier, P.; Beck-Nielsen, H.; Brosen, K. The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c Pharmacogenet. Genomics 2011, 21 (12) 837-50
49. Higgins, J. W.; Bedwell, D. W.; Zamek-Gliszczynski, M. J. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics Drug Metab. Dispos. 2012, 40 (6) 1170-7
50. Kirpichnikov, D.; McFarlane, S. I.; Sowers, J. R. Metformin: an update Ann. Intern. Med. 2002, 137 (1) 25-33
51. Lin, H. Z.; Yang, S. Q.; Chuckaree, C.; Kuhajda, F.; Ronnet, G.; Diehl, A. M. Metformin reverses fatty liver disease in obese, leptin-deficient mice Nat. Med. 2000, 6 (9) 998-1003
52. Gangale, M. F.; Miele, L.; Lanzone, A.; Sagnella, F.; Martinez, D.; Tropea, A.; Moro, F.; Morciano, A.; Ciardulli, A.; Palla, C.; Pompili, M.; Cefalo, C.; Grieco, A.; Apa, R. Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome Clin. Endocrinol. (Oxford) 2011, 75 (4) 520-7
53. Palomba, S.; Falbo, A.; Carrillo, L.; Villani, M. T.; Orio, F.; Russo, T.; Di Cello, A.; Cappiello, F.; Capasso, S.; Tolino, A.; Colao, A.; Mastrantonio, P.; La Sala, G. B.; Zullo, F.; Cittadini, E. Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial Fertil. Steril. 2011, 96 (6) 1384-1390
54. Cheong, J. H.; Park, E. S.; Liang, J.; Dennison, J. B.; Tsavachidou, D.; Nguyen-Charles, C.; Cheng, K. W.; Hall, H.; Zhang, D.; Lu, Y.; Ravoori, M.; Kundra, V.; Ajani, J. A.; Lee, J. S.; Hong, W. K.; Mills, G. B. Dual inhibition of Tumor Energy Pathway by 2-deoxy glucose and metformin Is Effective Against a Broad Spectrum of Preclinical Cancer Models Mol. Cancer Ther. 2011, 10 (12) 2350-62
55. Roe, A. L.; Howard, G.; Blouin, R.; Snawder, J. E. Characterization of cytochrome P450 and glutathione S-transferase activity and expression in male and female ob/ob mice Int. J. Obes. Relat. Metab. Disord. 1999, 23 (1) 48-53
56. Sambol, N. C.; Chiang, J.; O'Conner, M.; Liu, C. Y.; Lin, E. T.; Goodman, A. M.; Benet, L. Z.; Karam, J. H. Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus J. Clin. Pharmacol. 1996, 36 (11) 1012-21
57. Hermann, L. S. Metformin: a review of its pharmacological properties and therapeutic use Diabete Metab. 1979, 5 (3) 233-45